Antisickling Agents

DBCAT001227Pharmacologic class

Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. A DrugBank category of 4 drugs. 1 of them is approved.

Also known as: Agents, Antisickling · Agents, Desickling · Desickling Agents
Drugs: Cetiedil
Efaproxiral
Hydroxyurea
Methyl isocyanate

What you can answer from here — as of August 24, 2016

4DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

78Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Antisickling Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account